Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Report ID | 1184 |
Drug Identification Number | 02314932 |
Brand name | LEVOFLOXACIN IN 5% DEXTROSE INJECTION |
Common or Proper name | Levofloxacin |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LEVOFLOXACIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250mg / 50mL x 24 & 500mg/100mL x 24 & 750mg/150mL x24 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2015-11-09 |
Estimated end date | 2017-06-14 |
Actual end date | 2017-06-14 |
Shortage status | Resolved |
Updated date | 2017-06-15 |
Company comments | Resolved June 14, 2017 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2017-06-15 | English | Compare |
v8 | 2017-06-14 | French | Compare |
v7 | 2017-06-14 | English | Compare |
v6 | 2017-06-05 | French | Compare |
v5 | 2017-06-05 | English | Compare |
v4 | 2017-05-05 | French | Compare |
v3 | 2017-05-05 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 9 of 9